Has Rahul Malhotra, MD received payments from drug or device companies?

Yes. Drug and device makers reported $103,303 in general payments to Rahul Malhotra, MD across 907 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rahul Malhotra, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rahul Malhotra, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rahul Malhotra, MD

Interventional Cardiology · Glendale, AZNPI 1629079876

Payments from drug & device makers

$103,303in general payments, 2019–2025

Across 907 payments — averaging $113.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Penumbra, Inc.$20K
Medtronic$19K
Boston Scientific$19K
Angiodynamics, Inc.$15K
EKOS Corporation$5K
Veniti, Inc.$4K
plus $20K from 54 others

$1,070in research payments, 2019–2025

Across 2 payments — averaging $535.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cook Research Incorporated$1K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Penumbra, Inc.	61	$20,468
Medtronic(2 entities)	158	$19,352
Boston Scientific	86	$19,012
Angiodynamics, Inc.	9	$15,468
EKOS Corporation	1	$5,200
Veniti, Inc.	2	$4,250
Cook Research Incorporated	3	$2,300
Amgen	113	$2,037
Abbott	33	$1,541
Endologix LLC	10	$1,539
Abiomed	31	$1,445
Novartis	46	$966
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	38	$776
AstraZeneca	24	$679
Merck	27	$584
Cook Medical LLC	9	$564
Recor Medical Inc	10	$554
Pfizer	34	$543
Novo Nordisk	21	$527
E.r. Squibb & Sons, L.L.C.	30	$512
Kestra Medical Technology Services, Inc.	18	$443
Biosense Webster, Inc.	6	$440
Tactile Systems Technology Inc	10	$381
Imperative Care, Inc	4	$315
Boehringer Ingelheim	14	$294
Cardinal Health 200 LLC	2	$284
Siemens Medical Solutions USA, Inc.	3	$268
Impulse Dynamics (USA) Inc.	7	$259
Bardy Diagnostics, Inc.	10	$255
Stryker	5	$232
Johnson & Johnson	14	$223
Cvrx, Inc.	4	$195
Actelion Pharmaceuticals US, Inc.	7	$193
Shockwave Medical, Inc	1	$125
Asahi Intecc USA, Inc.	1	$120
Lexicon Pharmaceuticals, Inc.	5	$102
Biocompatibles, Inc.	5	$78
Amarin Pharma, Inc.	5	$68
Kowa Pharmaceuticals America, Inc.	5	$63
Alnylam Pharmaceuticals Inc.	3	$57
Regeneron Healthcare Solutions, Inc.	3	$48
Mimedx Group, Inc.	1	$46
Cordis US CORP.	2	$43
Chiesi USA, Inc.	3	$42
Kiniksa Pharmaceuticals, Ltd.	2	$40
Cardiva Medical, Inc.	2	$35
Cardiovascular Systems Inc.	2	$31
Daiichi Sankyo Inc.	1	$28
Arbor Pharmaceuticals, Inc.	2	$28
Inspire Medical Systems, Inc.	1	$25
Terumo Medical Corporation	1	$23
Venclose Inc.	1	$23
Inari Medical, Inc.	1	$20
Avinger Inc.	1	$20
Esperion Therapeutics, Inc.	1	$20
W. L. Gore & Associates, Inc.	1	$18
Bard Peripheral Vascular, Inc.	1	$17
Veryan Medical Incorporated	1	$17
Azurity Pharmaceuticals, Inc.	1	$15
Lilly USA, LLC	1	$15

How this compares

$103,303 in reported general payments places this provider in the 80th percentile of 223 interventional cardiology providers in Arizona.

See all interventional cardiology providers in Arizona →

Medicare billing

Part B allowed, 2024

$918,370

Medicare patients

662

Services billed

7,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Glendale

Anthony PozunGlendale$99K
Paul SorajjaPhoenix$8.8M
Thomas WaggonerTucson$4.1M
Hursh NaikAvondale$2.2M
Nabil DibGilbert$2.2M
Timothy ByrnePhoenix$2.1M
Ashish PershadChandler$1.4M
Mohamad LazkaniPhoenix$1.1M
Parminder SinghPhoenix$854K
Samuel ButmanCottonwood$706K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →